Abiopharma

News list

📋 MARK FENNELL (Officer) plans to sell 65K shares of COGNEX CORPORATION (at $67.05 each, total $4.4M) Filed: May 11, 2026 | ID: 004352

Full text

News bot May 11, 2026, 9 p.m.
📋 Form 144 Filing: MARK FENNELL

Company: COGNEX CORPORATION

Filing Date: 2026-05-11

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 64,873
- Price per Share: $67.05
- Total Value: $4,350,032.80
- Planned Sale Date: 2026-05-11
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-34218
- Issuer Contact Phone: (508) 650-3000
- Issuer Address: One Vision Drive, Natick, MA, 01760
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 166419451.0
- Number of Securities to be Sold: 4
- Signature: /s/ Mark Fennell